UBE2S and ovarian carcinoma: Mengjun Zhang et al. observed that UBE2S can promote PI3K or mTOR signaling pathway, block the regulation of cell cycle, inhibit cell apoptosis, and promote the proliferation, migration, and prognosis of ovarian cancer (Zhang et al., 2022b).